Mats Heyman Selected Research

ATP dependent 26S protease (26S proteasome)

1/2013

Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mats Heyman Research Topics

Disease

32	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 08/2005
10	Neoplasms (Cancer) 01/2021 - 08/2008
6	Leukemia 12/2022 - 02/2008
5	Hypersensitivity (Allergy) 01/2021 - 03/2015
5	Pancreatitis 01/2021 - 04/2014
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019 - 06/2007
4	Infections 01/2019 - 02/2008
3	Thrombosis (Thrombus) 01/2022 - 02/2015
3	Residual Neoplasm 01/2019 - 05/2013
2	Seizures (Absence Seizure) 01/2022 - 07/2020
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 03/2015
2	Hemorrhage 01/2022 - 02/2015
2	Down Syndrome (Down's Syndrome) 01/2021 - 04/2011
2	Disease Progression 01/2019 - 04/2014
2	Hematologic Neoplasms (Hematological Malignancy) 02/2017 - 02/2008
1	Renal Insufficiency (Renal Failure) 01/2022
1	Posterior Leukoencephalopathy Syndrome 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Osteonecrosis (Kienbock's Disease) 01/2019
1	Pancreatic Pseudocyst 01/2019
1	Thromboembolism 01/2019
1	Virus Diseases (Viral Diseases) 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Second Primary Neoplasms (Neoplasms, Second) 10/2017
1	Hypertriglyceridemia 10/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2017
1	Philadelphia Chromosome 02/2016
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2013
1	Multiple Myeloma 01/2013
1	T-Cell Leukemia (Leukemia, T Cell) 04/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2011
1	Erythema Infectiosum (Fifth Disease) 02/2008
1	Cytopenia 02/2008
1	Viremia 02/2008

Drug/Important Bio-Agent (IBA)

10	Asparaginase (Elspar)FDA Link 11/2022 - 04/2014
8	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 05/2022 - 06/2009
7	Methotrexate (Mexate)FDA LinkGeneric 05/2022 - 06/2009
4	Pharmaceutical PreparationsIBA 01/2019 - 08/2008
3	EnzymesIBA 11/2022 - 01/2019
3	pegaspargase (Oncaspar)FDA Link 01/2021 - 03/2015
2	UbiquitinIBA 12/2022 - 06/2007
2	2-mercaptopurineIBA 05/2022 - 10/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2020 - 11/2007
2	DeoxycytidineIBA 01/2020 - 02/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 02/2017
2	RNA (Ribonucleic Acid)IBA 01/2019 - 12/2013
2	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 10/2017 - 05/2014
2	GlucocorticoidsIBA 10/2012 - 11/2007
2	Dacarbazine (DIC)FDA LinkGeneric 03/2011 - 02/2008
1	Thioguanine (Tioguanine)FDA Link 05/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	AntigensIBA 01/2019
1	AsparagineIBA 01/2019
1	CoagulaseIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	AntithrombinsIBA 10/2017
1	LipidsIBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 02/2017
1	Cytostatic AgentsIBA 02/2017
1	KIR ReceptorsIBA 01/2017
1	SteroidsIBA 02/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2015
1	Biological ProductsIBA 01/2015
1	antiarrhythmic peptide (AAP)IBA 04/2014
1	Messenger RNA (mRNA)IBA 03/2014
1	Bortezomib (Velcade)FDA Link 01/2013
1	ATP dependent 26S protease (26S proteasome)IBA 01/2013
1	MicroRNAs (MicroRNA)IBA 10/2012
1	Angiogenesis InhibitorsIBA 09/2009
1	Vincristine (Oncovin)FDA LinkGeneric 08/2008
1	DNA (Deoxyribonucleic Acid)IBA 02/2008
1	Cyclin-Dependent Kinase Inhibitor p27IBA 08/2007
1	Notch1 ReceptorIBA 06/2007
1	F-Box ProteinsIBA 06/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2005
1	Caspase 2IBA 08/2005

Therapy/Procedure

21	Therapeutics 05/2022 - 02/2008
5	Drug Therapy (Chemotherapy) 01/2022 - 02/2008
2	Hematopoietic Stem Cell Transplantation 01/2018 - 05/2013
2	Stem Cell Transplantation 04/2012 - 04/2011
1	Critical Care (Surgical Intensive Care) 12/2021
1	Catheters 01/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2019
1	Transplantation 01/2019
1	Immunotherapy 01/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Treatment Delay 02/2016
1	Remission Induction 04/2012
1	Blood Transfusion (Blood Transfusions) 02/2008